Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting-Reference-Cited by-同舟云学术

Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting

Published:2022-09-02 Issue:3 Volume:31 Page:254-262
ISSN:2508-6235
Container-title:Journal of Obesity & Metabolic Syndrome
language:en
Short-container-title:Journal of Obesity & Metabolic Syndrome

Author:

Ko Hae-Jin¹²,Kim Jin-Wook³⁴,Lim Soo⁵^ORCID

Affiliation:

1. Department of Family Medicine, School of Medicine, Kyungpook National University, Daegu, Korea

2. Department of Family Medicine, Kyungpook National University Hospital, Daegu, Korea

3. Department of Family Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea

4. Department of Family Medicine, Korea University College of Medicine, Seoul, Korea

5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea

Publisher

Korean Society for the Study of Obesity

Subject

Endocrinology, Diabetes and Metabolism

Link

http://pdf.medrang.co.kr/KSSO2/2022/031/KSSO2031-03-254.pdf

Reference34 articles.

1. World Health Organization. Obesity and overweight [Internet]. Geneva:World Health Organization; 2021 [cited 2022 Aug 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

2. Obesity Fact Sheet in Korea, 2020: Prevalence of Obesity by Obesity Class from 2009 to 2018

3. 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea

4. Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder

5. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion;Journal of Colloid and Interface Science;2024-12

2. Clinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors;Asploro Journal of Biomedical and Clinical Case Reports;2024-08-05

3. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice;Drug Design, Development and Therapy;2024-03

4. Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures;Diabetes, Obesity and Metabolism;2024-01-19

5. Role of pharmacists in the management of patients with obesity;Arhiv za farmaciju;2024